News

The Centers for Medicare & Medicaid Services released wage data to help hospitals assess whether to seek reclassification of their Medicare area wage index for fiscal year 2022.

Hospitals have treated at least 15 patients in Arizona and New Mexico for methanol poisoning associated with alcohol-based hand sanitizers, according to a report released by the Centers for Disease Control and Prevention. Six of the patients developed seizures, four died and three were discharged with visual impairment.

The National Institutes of Health announced the Medical Imaging and Data Resource Center, a public-private initiative that will create medical imaging tools to detect and personalize therapies for COVID-19 patients.

The National Institute of Allergy and Infectious Diseases has launched a clinical trial to evaluate a potential COVID-19 treatment regimen for hospitalized patients that combines remdesivir with interferon beta-1a, a medication approved to treat multiple sclerosis that laboratory studies suggest may benefit patients with COVID-19. T

AHA’s Advancing Health podcast channel recently ranked 7th on Feedspot’s Top 55 Healthcare Leadership Podcasts To Follow in 2020.

More than one in four individuals in a recent national survey reported they would wait four months or longer to seek previously skipped medical care due to fear of COVID-19.

Michael Schmidt, researcher at the Medical University of South Carolina and co-director of Environmental & Health Crimes at the National Mass Violence Victimization Resource Center, unveils a new partnership between his organization and AHA’s Hospitals Against Violence initiative, which is designed to support hospitals and health systems in caring for victims and communities impacted by mass violence incidents.

The Centers for Medicare & Medicaid Services and Department of the Treasury approved a Section 1332 waiver for New Hampshire to implement a five-year reinsurance program for its individual health insurance market beginning in 2021.

Missouri voters approved an expansion of the state’s Medicaid initiative, the second state to do so during the COVID-19 pandemic.

Health care facilities or providers facing inadequate supplies of certain drugs needed to treat patients with COVID-19 should not use the products more than four hours beyond the labeled “in-use time” for refrigerated storage or two hours beyond the labeled “in-use time” for room temperature storage, the Food and Drug Administration announced.

The departments of Health and Human Services and Defense will pay Janssen Pharmaceutical Companies of Johnson & Johnson $1 billion to manufacture 100 million doses of its COVID-19 vaccine candidate for use in clinical trials, or to vaccinate Americans if authorized by the Food and Drug Administration.

The Centers for Medicare & Medicaid Services Aug. 4 released a proposed rule that would retroactively incorporate Medicare Advantage days into the Medicare fraction of a hospital’s disproportionate patient percentage for the Medicare Disproportionate Share Hospital program.

The Centers for Medicare & Medicaid Services Aug. 3 issued a proposed rule that would update physician fee schedule payments for calendar year 2021.

The Centers for Medicare & Medicaid Services released the calendar year 2021 outpatient prospective payment system/ambulatory surgical center proposed rule.

Health care providers should know the symptoms of acute flaccid myelitis and immediately hospitalize those who exhibit them, the Centers for Disease Control said.

A series of free videos from Med Tac offers guidance on how essential workers and the public can stay safe during the COVID-19 public health emergency.

The AHA, American Medical Association, American Society of Health-System Pharmacists, and United States Pharmacopeia convened a virtual summit to examine the resilience of the U.S. pharmaceutical supply chain in light of the current state of global pharmaceutical manufacturing.

The National Institutes of Health announced clinical trials to investigate the safety and efficacy of a synthetic antibody therapy in COVID-19 patients.

The Centers for Medicare & Medicaid Services will allow health insurers to offer premium reductions for individuals with 2020 coverage in the individual and small group markets when consistent with state law, the agency announced.

The Department of Health and Human Services released specifications for reporting certain COVID-19 laboratory data as required by the Coronavirus Aid, Relief, and Economic Security Act.